Published in J Virol on February 01, 2001
The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol (2003) 4.73
NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol (2004) 3.52
Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol (2006) 2.73
Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection. J Virol (2002) 2.55
Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J Virol (2002) 2.50
NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol (2009) 2.39
Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog (2008) 2.38
Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc Natl Acad Sci U S A (2006) 2.31
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. J Virol (2006) 2.22
Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog (2009) 2.17
A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog (2008) 2.12
Persistent Sin Nombre virus infection in the deer mouse (Peromyscus maniculatus) model: sites of replication and strand-specific expression. J Virol (2003) 2.09
The pathogenesis of Rift Valley fever. Viruses (2011) 2.02
Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J Virol (2003) 1.98
Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription. J Virol (2006) 1.97
Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol (2005) 1.96
Biological transmission of arboviruses: reexamination of and new insights into components, mechanisms, and unique traits as well as their evolutionary trends. Clin Microbiol Rev (2005) 1.91
La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol (2007) 1.90
Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system. J Virol (2005) 1.90
Inhibition of transcription and translation in Sindbis virus-infected cells. J Virol (2005) 1.89
Gouleako virus isolated from West African mosquitoes constitutes a proposed novel genus in the family Bunyaviridae. J Virol (2011) 1.73
Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment. J Virol (2005) 1.72
Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J Virol (2008) 1.69
Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. J Virol (2005) 1.68
Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death. J Virol (2003) 1.67
Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. Virology (2005) 1.63
Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. J Virol (2003) 1.54
Rift valley fever vaccines. Vaccine (2009) 1.47
Classical swine fever virus interferes with cellular antiviral defense: evidence for a novel function of N(pro). J Virol (2003) 1.42
Schmallenberg virus pathogenesis, tropism and interaction with the innate immune system of the host. PLoS Pathog (2013) 1.42
NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. J Virol (2011) 1.41
Correlative Gene Expression to Protective Seroconversion in Rift Valley Fever Vaccinates. PLoS One (2016) 1.40
Interaction of Bunyamwera Orthobunyavirus NSs protein with mediator protein MED8: a mechanism for inhibiting the interferon response. J Virol (2006) 1.36
Characterization of a novel Negevirus and a novel Bunyavirus isolated from Culex (Culex) declarator mosquitoes in Trinidad. J Gen Virol (2013) 1.26
Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. Ann N Y Acad Sci (2009) 1.24
Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells. J Virol (2012) 1.23
Rift valley fever: recent insights into pathogenesis and prevention. J Virol (2011) 1.21
Molecular biology and genetic diversity of Rift Valley fever virus. Antiviral Res (2012) 1.21
Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication. J Biol Chem (2012) 1.18
Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection. PLoS Negl Trop Dis (2012) 1.18
Discovery of a unique novel clade of mosquito-associated bunyaviruses. J Virol (2013) 1.17
Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines. Antiviral Res (2009) 1.16
Creation of a nonspreading Rift Valley fever virus. J Virol (2011) 1.16
The S segment of Punta Toro virus (Bunyaviridae, Phlebovirus) is a major determinant of lethality in the Syrian hamster and codes for a type I interferon antagonist. J Virol (2006) 1.13
Host alternation is necessary to maintain the genome stability of rift valley fever virus. PLoS Negl Trop Dis (2011) 1.12
Creation of a recombinant Rift Valley fever virus with a two-segmented genome. J Virol (2011) 1.08
Establishment of a bluetongue virus infection model in mice that are deficient in the alpha/beta interferon receptor. PLoS One (2009) 1.08
Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist. J Virol (2003) 1.07
Characterization of Rift Valley fever virus transcriptional terminations. J Virol (2007) 1.06
Development of a RVFV ELISA that can distinguish infected from vaccinated animals. Virol J (2009) 1.05
p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production. PLoS One (2012) 1.03
Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis. J Virol (2012) 1.02
Essential role of the NV protein of Novirhabdovirus for pathogenicity in rainbow trout. J Virol (2004) 1.02
Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice. PLoS Negl Trop Dis (2011) 1.00
The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine. J Virol (2012) 0.99
Antiviral autophagy restrictsRift Valley fever virus infection and is conserved from flies to mammals. Immunity (2013) 0.99
Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep. Vaccine (2012) 0.99
Design of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype. J Virol (2011) 0.98
Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift valley fever virus in human small airway epithelial cells. PLoS One (2010) 0.98
Molecular biology of rift valley Fever virus. Open Virol J (2010) 0.98
Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge. J Virol (2012) 0.97
Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy. J Vis Exp (2011) 0.96
Bunyaviruses and the type I interferon system. Viruses (2009) 0.96
Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH. J Virol (2014) 0.96
Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice. PLoS One (2011) 0.95
Species-independent bioassay for sensitive quantification of antiviral type I interferons. Virol J (2010) 0.93
Innate immune response to Rift Valley fever virus in goats. PLoS Negl Trop Dis (2012) 0.93
Innate antiviral response: role in HIV-1 infection. Viruses (2011) 0.93
Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse. PLoS Negl Trop Dis (2012) 0.92
A five-amino-acid deletion of the eastern equine encephalitis virus capsid protein attenuates replication in mammalian systems but not in mosquito cells. J Virol (2008) 0.92
RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge. J Virol (2013) 0.92
Phleboviruses and the Type I Interferon Response. Viruses (2016) 0.90
The role of interferon antagonist, non-structural proteins in the pathogenesis and emergence of arboviruses. Viruses (2011) 0.90
Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments. J Virol (2015) 0.89
Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection. PLoS One (2011) 0.89
Curcumin inhibits Rift Valley fever virus replication in human cells. J Biol Chem (2012) 0.89
Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes. PLoS Negl Trop Dis (2014) 0.89
Novel approaches to develop Rift Valley fever vaccines. Front Cell Infect Microbiol (2012) 0.88
Characterization of the Sandfly fever Naples species complex and description of a new Karimabad species complex (genus Phlebovirus, family Bunyaviridae). J Gen Virol (2013) 0.88
Interferon-stimulated poly(ADP-Ribose) polymerases are potent inhibitors of cellular translation and virus replication. J Virol (2013) 0.88
A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep. Vector Borne Zoonotic Dis (2014) 0.87
Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep. Vector Borne Zoonotic Dis (2013) 0.87
Functional analysis of Rift Valley fever virus NSs encoding a partial truncation. PLoS One (2012) 0.87
Advances in Rift Valley fever research: insights for disease prevention. Curr Opin Infect Dis (2010) 0.87
Rift Valley Fever Vaccine Development, Progress and Constraints. Emerg Infect Dis (2011) 0.87
Non-structural proteins of arthropod-borne bunyaviruses: roles and functions. Viruses (2013) 0.85
Metagenomic shotgun sequencing of a Bunyavirus in wild-caught Aedes aegypti from Thailand informs the evolutionary and genomic history of the Phleboviruses. Virology (2014) 0.85
A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs. PLoS One (2013) 0.85
Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model. PLoS Negl Trop Dis (2014) 0.85
Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging. J Virol (2014) 0.85
Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses. J Virol (2013) 0.84
The Rift Valley Fever virus protein NSm and putative cellular protein interactions. Virol J (2012) 0.83
Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response. Virology (2009) 0.82
Comparative pathogenesis and systems biology for biodefense virus vaccine development. J Biomed Biotechnol (2010) 0.82
Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice. J Gen Virol (2013) 0.82
Hantavirus regulation of type I interferon responses. Adv Virol (2012) 0.81
How cells respond to interferons. Annu Rev Biochem (1998) 24.27
Functional role of type I and type II interferons in antiviral defense. Science (1994) 18.92
Immune response in mice that lack the interferon-gamma receptor. Science (1993) 12.15
Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology (1998) 9.81
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol (2000) 7.00
Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol (2000) 6.22
The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci U S A (1992) 4.74
Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev (1998) 4.06
When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology (1996) 4.02
Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc Natl Acad Sci U S A (1996) 3.80
Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol (2000) 3.77
Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc Natl Acad Sci U S A (2000) 3.51
The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizzotic and virological studies. Trans R Soc Trop Med Hyg (1979) 3.35
Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am J Trop Med Hyg (1995) 3.08
JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity (1999) 2.74
Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol (1985) 2.71
Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses. Virology (1991) 2.18
Genetically determined, interferon-dependent resistance to influenza virus in mice. J Exp Med (1979) 2.14
Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. Vaccine (1990) 1.82
The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice. J Virol (2000) 1.79
The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules. J Virol (1995) 1.77
Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation. Virus Res (1997) 1.76
An IkappaB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J Virol (1996) 1.73
Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine. Br J Exp Pathol (1949) 1.71
Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis. Am J Trop Med Hyg (1991) 1.70
Products of the porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR. J Virol (1994) 1.70
Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections. J Virol (1999) 1.62
Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator. Antiviral Res (1986) 1.55
The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. Virology (1999) 1.46
A recombinant human interferon-alpha B/D hybrid with a broad host-range. J Gen Virol (1987) 1.42
Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus. Virology (1989) 1.38
Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response. Arch Virol (1990) 1.31
Inhibition of nuclear factor kappaB activation by a virus-encoded IkappaB-like protein. J Biol Chem (1998) 1.30
Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha. Rev Infect Dis (1989) 1.22
Analysis of the 3' terminal sequence recognized by the Rift Valley fever virus transcription complex in its ambisense S segment. Virology (1997) 1.19
Rift Valley Fever Virus Hepatitis: Light and Electron Microscopic Studies in the Mouse. Am J Pathol (1963) 1.13
Viral determinants of virulence for Rift Valley fever (RVF) in rats. Microb Pathog (1988) 1.13
The Rift Valley fever virus nonstructural protein NSs is phosphorylated at serine residues located in casein kinase II consensus motifs in the carboxy-terminus. Virology (1999) 1.09
In situ analysis of proteolipid protein gene transcripts during persistent Theiler's virus infection. J Histochem Cytochem (1991) 1.01
Induction of virus-inhibiting factor or interferon in mice by strains with different virulence of Rift Valley fever virus. Kitasato Arch Exp Med (1972) 1.01
Functional role of type I and type II interferons in antiviral defense. Science (1994) 18.92
Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J (1995) 6.94
Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell (1986) 4.92
A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science (2001) 4.53
Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol (1990) 3.44
Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol Cell Biol (1988) 3.32
cDNA structures and regulation of two interferon-induced human Mx proteins. Mol Cell Biol (1989) 3.20
Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc Natl Acad Sci U S A (1983) 3.17
Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol (1977) 3.05
Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med (1985) 2.95
Host gene influences sensitivity to interferon action selectively for influenza virus. Nature (1980) 2.88
Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J Virol (1992) 2.88
Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84
Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J Exp Med (1994) 2.53
A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J (1998) 2.48
The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol (1995) 2.47
Inborn resistance of ice to orthomyxoviruses. Curr Top Microbiol Immunol (1981) 2.41
Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol (2001) 2.40
Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo. Nature (1977) 2.39
Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product. J Virol (1985) 2.38
Adult mouse hepatocytes in primary monolayer culture express genetic resistance to mouse hepatitis virus type 3. J Immunol (1982) 2.32
Interferon-induced protein Mx accumulates in nuclei of mouse cells expressing resistance to influenza viruses. Virology (1985) 2.26
Genetically determined, interferon-dependent resistance to influenza virus in mice. J Exp Med (1979) 2.14
Polyclonal and monoclonal antibodies to the interferon-inducible protein Mx of influenza virus-resistant mice. J Biol Chem (1985) 2.10
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). Clin Infect Dis (2012) 2.07
Induction of the PML protein by interferons in normal and APL cells. Leukemia (1995) 2.05
Transcriptional activation of the mouse Mx gene by type I interferon. Mol Cell Biol (1986) 2.04
The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci U S A (1995) 1.99
Interferon-induced Mx protein: a mediator of cellular resistance to influenza virus. Interferon (1987) 1.99
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood (2001) 1.98
Natural killer cells in the mouse: an alternative immune surveillance mechanism? Contemp Top Immunobiol (1978) 1.96
High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J Virol (2000) 1.94
A family of interferon-induced Mx-related mRNAs encodes cytoplasmic and nuclear proteins in rat cells. J Virol (1988) 1.90
Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci U S A (1999) 1.84
The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures. FEBS Lett (1999) 1.81
Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids. Proc Natl Acad Sci U S A (1999) 1.78
Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection. Infect Immun (1994) 1.77
Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J Virol (1996) 1.76
Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein. J Virol (1991) 1.74
Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. J Virol (1995) 1.73
Mx-dependent resistance to influenza viruses is induced by mouse interferons alpha and beta but not gamma. Virology (1984) 1.71
Interferon-induced human protein with homology to protein Mx of influenza virus-resistant mice. Mol Cell Biol (1985) 1.70
Human cytomegalovirus immediate early and late transcripts are expressed in all major leukocyte populations in vivo. J Infect Dis (1995) 1.70
Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis. Infect Immun (1999) 1.68
Role of interleukin-1 in the pathogenesis of experimental shigellosis. J Clin Invest (1995) 1.67
Strategy for the detection of Helicobacter species by amplification of 16S rRNA genes and identification of H. felis in a human gastric biopsy. Res Microbiol (1997) 1.65
A functional GTP-binding motif is necessary for antiviral activity of Mx proteins. J Virol (1993) 1.64
Mechanism of human MxA protein action: variants with changed antiviral properties. EMBO J (1992) 1.63
Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections. J Virol (1999) 1.62
Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection. Infect Immun (1998) 1.61
A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins. Virology (1998) 1.60
Attenuated virulence of uridine-uracil auxotrophs of Aspergillus fumigatus. Infect Immun (1996) 1.60
Characterization of the 5' and 3' ends of viral messenger RNAs isolated from BHK21 cells infected with Germiston virus (Bunyavirus). Virology (1990) 1.59
Germinal centre CD4+ T cells are an important site of HIV replication in vivo. AIDS (1997) 1.58
Enhanced virus resistance of transgenic mice expressing the human MxA protein. J Virol (1995) 1.56
Infection of rabbit Peyer's patches by Shigella flexneri: effect of adhesive or invasive bacterial phenotypes on follicle-associated epithelium. Infect Immun (1996) 1.54
Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med (1995) 1.54
Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J Virol (1998) 1.53
Activity of rat Mx proteins against a rhabdovirus. J Virol (1990) 1.52
Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest (1995) 1.49
Cloning and disruption of the gene encoding an extracellular metalloprotease of Aspergillus fumigatus. Mol Microbiol (1994) 1.49
Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J Virol (2000) 1.48
Inborn resistance of mice to myxoviruses: macrophages express phenotype in vitro. J Exp Med (1978) 1.46
Mx proteins: GTPases with antiviral activity. Trends Cell Biol (1993) 1.45
Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity. J Virol (1997) 1.44
Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc Natl Acad Sci U S A (1995) 1.43
MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J Virol (1993) 1.43
[Infected myxoma as a cause of acute infective endocarditis]. Vnitr Lek (2010) 1.42
CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. Mol Cell Biol (2000) 1.39
Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children. Virchows Arch (2001) 1.39
A Canadian hospital-based HIV/hepatitis C look-back notification program. CMAJ (1997) 1.38
Overexpression of the influenza virus polymerase can titrate out inhibition by the murine Mx1 protein. J Virol (1992) 1.36
Genetically determined resistance to infection by hepatotropic influenza A virus in mice: effect of immunosuppression. Infect Immun (1976) 1.35
GTP-bound human MxA protein interacts with the nucleocapsids of Thogoto virus (Orthomyxoviridae). J Biol Chem (1999) 1.34
Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J Virol (1994) 1.34
Function of the mouse Mx1 protein is inhibited by overexpression of the PB2 protein of influenza virus. Virology (1993) 1.34
Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-alpha formation and neutrophil sequestration into the murine lungs. J Immunol (1998) 1.33
Roles of macrophages in measles virus infection of genetically modified mice. J Virol (2001) 1.33
Molecular detection and characterization of yellow fever virus in blood and liver specimens of a non-vaccinated fatal human case. J Med Virol (1997) 1.32
Antiviral state against influenza virus neutralized by microinjection of antibodies to interferon-induced Mx proteins. EMBO J (1988) 1.32
MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J Infect Dis (1994) 1.29
Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus. J Virol (1992) 1.28
Rapid detection of influenza virus H1 by the polymerase chain reaction. Biochem Biophys Res Commun (1990) 1.26
Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus. J Exp Med (1981) 1.24
Origin of 1997-98 Rift Valley fever outbreak in East Africa. Lancet (1998) 1.24
Host gene influence on interferon action in adult mouse hepatocytes: specificity for influenza virus. Virology (1980) 1.23
Corynebacterium parvum-induced peritoneal exudate cells with rapid cytolytic activity against tumour cells are non-phagocytic cells with characteristics of natural killer cells. Scand J Immunol (1978) 1.23
Athymic (nude) mice express gene for myxovirus resistance. Nature (1974) 1.23
Nucleoprotein viral RNA and mRNA of Thogoto virus: a novel "cap-stealing" mechanism in tick-borne orthomyxoviruses? J Virol (1996) 1.20
Interferon-regulated influenza virus resistance gene Mx is localized on mouse chromosome 16. J Virol (1986) 1.20
Specific detection of fusarium species in blood and tissues by a PCR technique. J Clin Microbiol (1999) 1.19
Generation of natural killer cells: an autonomous function of the bone marrow. J Exp Med (1977) 1.19
Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent. J Immunol (1977) 1.19
Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus. Virology (1992) 1.17
Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines. J Virol (1991) 1.17
Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics. J Control Release (1999) 1.16
AGS3, an alpha(1-3)glucan synthase gene family member of Aspergillus fumigatus, modulates mycelium growth in the lung of experimentally infected mice. Fungal Genet Biol (2006) 1.15
MxA GTPase blocks reporter gene expression of reconstituted Thogoto virus ribonucleoprotein complexes. J Virol (2000) 1.14